Company Overview and News

to your dashboard

Headline News

Can ResMed (RMD) Maintain Balanced Growth in Q2 Earnings?

17h zacks
ResMed (RMD - Free Report) is slated to report second-quarter fiscal 2018 results, after markets close on Jan 22. Last quarter, the company delivered a positive earnings surprise of 1.5%. Moreover, ResMed has delivered positive earnings surprises in the trailing four quarters, with an average beat of 2.5%. Let's see how things are shaping up for this announcement. (18-0)

Your Daily Pharma Scoop: Lipocine Ahead Of Ad Com, Ohr's MAKO Study Fails, Zafgen Provides Update

2018-01-06 seekingalpha
Today we will discuss Lipocine (LPCN), which fell more than 10% on Friday ahead of the Ad Com for its lead product candidate TLANDO, an oral testosterone replacement therapy (TRT). (243-7)

The 10 Best Stocks to Buy for the Next Decade

2017-12-27 investorplace
Last year, InvestorPlace contributor Dan Burrows highlighted the 10 best-performing S&P 500 stocks of the past decade. The most important lesson one finds studying these high-flying stocks is that patience wins out over all other attributes of a successful investor. (335-3)

ResMed (RMD) Rides on Innovation Amid Reimbursement Woes

2017-12-01 zacks
On Dec 1, 2017, we issued an updated research report on leading medical devices company, ResMed Inc. (RMD - Free Report) . The stock carries a Zacks Rank #3 (Hold). (6-0)

Free Post Earnings Research Report: ResMed’s Revenue and EPS Jumped 13% Y-O-Y

2017-11-30 accesswire
LONDON, UK / ACCESSWIRE / November 30, 2017 / Active-Investors free earnings report on ResMed Inc. (NYSE: RMD) has freshly been issued to its members, and you can also sign up to view this report at ResMed reported its first quarter fiscal 2018 operating results on October 26, 2017. The maker of medical products for respiratory disorders outperformed top- and bottom-line expectations. (1-0)

Why Is ResMed (RMD) Up 8.4% Since the Last Earnings Report?

2017-11-29 zacks
It has been more than a month since the last earnings report for ResMed Inc. (RMD - Free Report) . Shares have added about 8.4% in that time frame, outperforming the market. (4-0)

UPDATE 1-Fisher & Paykel says UK court rules rival Resmed's patent is invalid

2017-11-12 reuters
* Legal proceedings still underway in Germany and U.S. (Adds context on wider legal proceedings, market reaction) (1-0)

Fisher & Paykel says UK court rules rival Resmed's patent is invalid

2017-11-12 reuters
WELLINGTON, Nov 13 (Reuters) - A British court has ruled that a patent held by health appliance firm Resmed Inc for a mask that treats sleep apnea was invalid, rival firm Fisher & Paykel Healthcare said on Monday. (1-0)

ResMed (RMD) Ranking Raised to Buy on Robust Quant Score

2017-11-08 investorplace
Currently, ResMed Inc (NYSE:RMD) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical. (1-1)

Project $1M: Returns ~18% P.A After Year 2

2017-11-06 seekingalpha
I started Project $1M with the goal of growing an initial stake of about $225k (which ultimately became $275k) into roughly $1M in 10 years. It implied the need to achieve an annualized return of close 13%, which would be a fairly incredible effort if a low churn portfolio were to achieve a result like that. We are now at the end Year 2 and so far the portfolio is performing materially better than expected. (47-2)

BRIEF-Resmed Inc ‍announces that AirMini, world's smallest pap device is now connected to AirView​

2017-11-06 reuters
* Resmed Inc - ‍announced that AirMini, world’s smallest pap device, is now connected to AirView​ Source text for Eikon: Further company coverage: (1-0)

MedTech Stock Q3 Earnings Roster for Oct 26: BSX, RMD & More

2017-10-25 zacks
The latest Earnings Preview depicts a bullish run in the ongoing reporting cycle. Till Oct 20, 87 S&P 500 members (24.7% of the total market cap) reported their numbers. Total earnings for these members have gone up 9.4% on 7.3% higher revenues. (93-0)

Can ResMed (RMD) Maintain Balanced Growth in Q1 Earnings?

2017-10-16 zacks
ResMed (RMD - Free Report) is slated to report first-quarter fiscal 2018 results, after markets close on Oct 26. Last quarter, the company delivered a positive earnings surprise of 2.7%. with average earnings beat of 1.7% for three of the trailing four quarters. Let's see how things are shaping up for this announcement. (37-0)

Daily Technical Summary Reports on Medical Equipment Stocks -- Invacare, ResMed, Stryker, and Zimmer Biomet

2017-10-13 prnewswire
If you want a Stock Review on IVC, RMD, SYK, or ZBH then come over to and sign up for your free customized report. For today, scans four equities to see how they have fared at the close of the last trading session: Invacare Corp. (NYSE: IVC), ResMed Inc. (NYSE: RMD), Stryker Corp. (NYSE: SYK), and Zimmer Biomet Holdings Inc. (NYSE: ZBH). Medical Appliances and Equipment companies primarily offer equipment and devices, which are designed for diagnosis, monitoring, and treatment of patients in healthcare systems worldwide. (29-0)